Experience With Botulinum Toxin Type A in Medically Intractable Pediatric Chronic Daily Headache
Authors:
- Kimberly Hall OasKOKimberly Hall Oas
- Kenneth J. MackKMKenneth J. Mack
- Ivan GarzaIGIvan Garza
- 1 November 2010
- journal article
- Published by Elsevier in Pediatric Neurology
- Vol. 43 (5) , 316-319
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Chronic daily headache in adolescentsNeurology, 2009
- Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Topiramate for Migraine Prevention in Pediatric Subjects 12 to 17 Years of AgePediatrics, 2009
- Management of Chronic Daily Headache in??Children and AdolescentsPediatric Drugs, 2008
- Chronic daily headache in adolescentsNeurology, 2006
- Pain Among Children and Adolescents: Restrictions in Daily Living and Triggering FactorsPediatrics, 2005
- Evidence for Antinociceptive Activity of Botulinum Toxin Type A in Pain ManagementHeadache: The Journal of Head and Face Pain, 2003
- Botulinum toxin type A (BOTOX) for treatment of migraineSeminars in Cutaneous Medicine and Surgery, 2001
- Botulinum toxin type A (BOTOX) for treatment of migraine headaches: An open‐label studyOtolaryngology–Head and Neck Surgery, 2000
- Botulinum Toxin Type A as a Migraine Preventive TreatmentHeadache: The Journal of Head and Face Pain, 2000
- Prophylactic Pharmacological Treatment of Chronic Daily HeadacheHeadache: The Journal of Head and Face Pain, 2000